9AT: RTW INVESTMENTS LP

other names

RTW INVESTMENTS LP
RTW INVESTMENTS, LLC

Adviser Profile

As of Date	03/30/2026
Registration	SEC, Approved, 06/13/2013
Other registrations (1)	SEC, ERA - Withdrawn, 06/04/2013
ADV Location	NEW YORK, NY, United States
Contact Info	646 xxxxxxx
Websites

AUM^*	14,137,925,887 60%
of that, discretionary	14,137,925,887 60%
Private Fund GAV^*	13,104,875,636 44%
Avg Account Size	1,413,792,589 60%
SMA’s	Yes
Private Funds	11 2

Adviser Type

- Large advisory firm

Number of Employees 70 19%

of those in investment advisory functions 35 9%

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

SEC Fund Type	Count	GAV
Fund TypeHedge Fund	Count6	GAV$12,820,517,322
Fund TypePrivate Equity Fund	Count4	GAV$284,358,314
Fund TypeVenture Capital Fund	Count1	GAV$

Adviser	Hedge Fund	Liquidity Fund	Private Equity Fund	Real Estate Fund	Securitized Asset Fund	Venture Capital Fund	Other Fund	Total Private Fund GAV	AUM	#Funds
Adviser ATAIROS MANAGEMENT, L.P.	Hedge Fund7.3b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV7.3b	AUM6.8b	#Funds2
Adviser NORTHCOAST ASSET MANAGEMENT LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV-	AUM5.0b	#Funds-
Adviser AXIUM INFRASTRUCTURE INC.	Hedge Fund7.1b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV7.1b	AUM9.3b	#Funds3
Adviser ARES SYSTEMATIC CREDIT LIMITED	Hedge Fund4.8b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV4.8b	AUM9.9b	#Funds3
Adviser MANIYAR CAPITAL ADVISORS UK LTD.	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV-	AUM1.5b	#Funds-
Adviser TIFF INVESTMENT MANAGEMENT	Hedge Fund5.3b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV5.3b	AUM8.6b	#Funds41
Adviser CAMDEN ASSET MANAGEMENT	Hedge Fund7.4b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV7.4b	AUM11.2b	#Funds14
Adviser CHURCHILL MANAGEMENT GROUP	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV-	AUM10.1b	#Funds-
Adviser CAPITAL FUND MANAGEMENT S.A.	Hedge Fund14.7b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV14.7b	AUM13.4b	#Funds20
Adviser PINNACLE ASSET MANAGEMENT, L.P.	Hedge Fund13.0b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund370.3m	Total Private Fund GAV13.3b	AUM8.9b	#Funds26

Stock Ticker	Stock Name	$ Position	% Position	$ Change	# Change
Stck Ticker558868105	Stock NameMADRIGAL PHARMACEUTICALS INC	$ Position$1,161,003,688	% Position12.00%	$ Change27.00%	# Change0.00%
Stck Ticker457669307	Stock NameINSMED INC	$ Position$842,854,661	% Position8.00%	$ Change90.00%	# Change57.00%
Stck Ticker69366J200	Stock NamePTC THERAPEUTICS INC	$ Position$588,417,683	% Position6.00%	$ Change24.00%	# Change0.00%
Stck Ticker04016X101	Stock NameARGENX SE	$ Position$566,377,302	% Position6.00%	$ Change14.00%	# Change0.00%
Stck Ticker74366E102	Stock NamePROTAGONIST THERAPEUTICS INC	$ Position$441,857,689	% Position4.00%	$ Change16.00%	# Change-12.00%
Stck Ticker750491102	Stock NameRADNET INC	$ Position$281,011,975	% Position3.00%	$ Change31.00%	# Change40.00%
Stck Ticker70975L107	Stock NamePENUMBRA INC	$ Position$269,403,204	% Position3.00%	$ Change23.00%	# Change0.00%
Stck Ticker632307104	Stock NameNATERA INC	$ Position$343,635,000	% Position3.00%	$ Change7.00%	# Change-25.00%
Stck Ticker19240Q201	Stock NameCOGENT BIOSCIENCES INC	$ Position$269,676,400	% Position3.00%	$ Change442.00%	# Change119.00%
Stck Ticker87650L103	Stock NameTARSUS PHARMACEUTICALS INC	$ Position$273,096,002	% Position3.00%	$ Change45.00%	# Change5.00%

Brochure Summary

Overview

RTW is a Delaware limited partnership founded and principally owned by Dr. Roderick Wong in February of 2010. Dr. Roderick Wong serves as RTW’s Managing Partner and Chief Investment Officer. RTW provides discretionary advisory services to: RTW Master Fund, Ltd. (“Flagship Master Fund”), RTW Offshore Fund One, Ltd. (“Flagship Offshore Fund”), RTW Onshore Fund One, LP (“Flagship Onshore Fund”), RTW Innovation Master Fund, Ltd. (“Innovation Master Fund”), RTW Innovation Offshore Fund, Ltd. (“Innovation Offshore Fund”), RTW Innovation Onshore Fund, LP (“Innovation Onshore Fund”), 4010 Royalty Master Fund, LP and 4010 Royalty Investments ICAV (“Royalty Master Funds” and, together with the Flagship Master Fund and the Innovation Master Fund”, the “Master Funds” and each, a “Master Fund”), 4010 Royalty Offshore FNT Fund, LP (“Royalty FNT Offshore Fund”), 4010 Royalty Offshore FT Fund, LP (“Royalty FT Offshore Fund”, and, together with the Flagship Offshore Fund, Innovation Offshore Fund, and Royalty FNT Offshore Fund, the “Offshore Funds” and each, an “Offshore Fund”), 4010 Royalty Onshore Fund, LP (“Royalty Onshore Fund” and, together with the Flagship Onshore Fund and the Innovation Onshore Fund, the “Onshore Funds” and each, an “Onshore Fund”), and RTW Co-Investment Series LLC (“Co-Investment Vehicle”), together with the first Series company under the Co-Investment Vehicle, Ji Xing Pharmaceuticals Series Supplement (“Ji Xing Series”), and RTW Biotech Opportunities

Ltd, formerly known as RTW Venture Fund Limited (“Biotech Opportunities Fund”). For the purpose of this document, the Flagship Master Fund, the Flagship Offshore Fund, and the Flagship Onshore Fund will collectively be referred to as the “Flagship Fund,” the Innovation Master Fund, Innovation Offshore Fund, and Innovation Onshore Fund will collectively be referred to as the “Innovation Fund”, and the Royalty Master Funds, the Royalty FNT Offshore Fund, the Royalty FT Offshore Fund, and the Royalty Onshore Fund will be referred to as the “Royalty Fund”. Each respective Onshore Fund and Offshore Fund invests a substantial portion of its assets in the related Master Fund. Unless specified, from hereinafter the Master Funds, the Offshore Funds, the Onshore Funds, the Co- Investment Vehicle, including the Ji Xing Series, and the Biotech Opportunities Fund will each be referred to as a “Fund” or collectively as the “Funds.” The Funds are managed pursuant to the objectives specified in the materials by which each Fund offers its ownership interests to investors. RTW does not tailor its services to individual client needs and the Funds’ investors do not have the right to specify, restrict, or influence the Funds’ investment objectives or any investment or trading decisions. RTW does not participate in wrap fee programs. As of December 31, 2023, RTW had $8,820,485,054 of regulatory assets under management, all of which were managed on a discretionary basis.

RTW INVESTMENTS LP

Adviser Profile

Details

Adviser Type

Client Types

Advisory Activities

Compensation Arrangments

Reported AUM

Private Funds

Employees

Private Funds Structure

Similar advisers

Top Holdings

Brochure Summary

Overview